InvestorsObserver
×
News Home

Will Oncology Institute Inc (TOI) Stay at the Top of the Healthcare Sector?

Tuesday, November 14, 2023 10:03 AM | InvestorsObserver Analysts

Mentioned in this article

Will Oncology Institute Inc (TOI) Stay at the Top of the Healthcare Sector?

The 83 rating InvestorsObserver gives to Oncology Institute Inc (TOI) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 81 percent of stocks in the Healthcare sector, TOI’s 83 overall rating means the stock scores better than 83 of all stocks.

Overall Score - 83
TOI has an Overall Score of 83. Find out what this means to you and get the rest of the rankings on TOI!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Oncology Institute Inc Stock Today?

Oncology Institute Inc (TOI) stock is lower by -3.14% while the S&P 500 is higher by 1.81% as of 9:57 AM on Tuesday, Nov 14. TOI is down -$0.08 from the previous closing price of $2.55 on volume of 62,428 shares. Over the past year the S&P 500 is up 13.49% while TOI is higher by 18.18%. TOI lost -$0.67 per share the over the last 12 months. Click Here to get the full Stock Report for Oncology Institute Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App